Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten F Gjerstorff

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|September 28, 2020
CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis AntigensMie K Jakobsen, Morten F Gjerstorff
Oncotarget|July 10, 2015
Oncogenic cancer/testis antigens: prime candidates for immunotherapyMorten F Gjerstorff, Mads H Andersen, Henrik J Ditzel
Human Reproduction (Oxford, England)|January 9, 2007
MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal developmentMorten F Gjerstorff, Kirsten Kock, Ole Nielsen, et al.
Cancer Immunology, Immunotherapy : CII|July 11, 2020
Augmenting engineered T-cell strategies in solid cancers through epigenetic primingAaraby Y Nielsen, Maria Ormhøj, Sofie Traynor, et al.
Protein Expression and Purification|June 16, 2010
Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapyMorten F Gjerstorff, Hüseyin Besir, Martin R Larsen, et al.
Plos One|August 8, 2015
Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast CancerEmeaga Maheswaran, Christina B Pedersen, Henrik J Ditzel, et al.
BMC Cancer|October 10, 2013
Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinomaMorten F Gjerstorff, Mette Pøhl, Karen E Olsen, et al.
Ugeskrift for Laeger|February 2, 2024
Odd Lilleng Gammelgaard, Per Guldberg, Morten F Gjerstorff, et al.
Molecular Oncology|June 24, 2021
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomesMikkel G Terp, Odd L Gammelgaard, Henriette Vever, et al.
International Journal of Oncology|May 11, 2006
Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epitheliaMorten F Gjerstorff, Vivian M Benoit, Anne-Vibeke Laenkholm, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|September 28, 2020
CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis AntigensMie K Jakobsen, Morten F Gjerstorff
Oncotarget|July 10, 2015
Oncogenic cancer/testis antigens: prime candidates for immunotherapyMorten F Gjerstorff, Mads H Andersen, Henrik J Ditzel
Human Reproduction (Oxford, England)|January 9, 2007
MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal developmentMorten F Gjerstorff, Kirsten Kock, Ole Nielsen, et al.
Cancer Immunology, Immunotherapy : CII|July 11, 2020
Augmenting engineered T-cell strategies in solid cancers through epigenetic primingAaraby Y Nielsen, Maria Ormhøj, Sofie Traynor, et al.
Protein Expression and Purification|June 16, 2010
Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapyMorten F Gjerstorff, Hüseyin Besir, Martin R Larsen, et al.
Plos One|August 8, 2015
Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast CancerEmeaga Maheswaran, Christina B Pedersen, Henrik J Ditzel, et al.
BMC Cancer|October 10, 2013
Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinomaMorten F Gjerstorff, Mette Pøhl, Karen E Olsen, et al.
Ugeskrift for Laeger|February 2, 2024
Odd Lilleng Gammelgaard, Per Guldberg, Morten F Gjerstorff, et al.
Molecular Oncology|June 24, 2021
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomesMikkel G Terp, Odd L Gammelgaard, Henriette Vever, et al.
International Journal of Oncology|May 11, 2006
Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epitheliaMorten F Gjerstorff, Vivian M Benoit, Anne-Vibeke Laenkholm, et al.
Pageof 4